Administration of Aggregated Beta-Amyloid Peptide (25–35) Induces Changes in Long-Term Potentiation in the Hippocampus in Vivo

被引：36
|
作者：
V. V. Trubetskaya
M. Yu. Stepanichev
M. V. Onufriev
N. A. Lazareva
V. A. Markevich
N. V. Gulyaeva
机构：
[1] Institute of Higher Nervous Activity and Neurophysiology,
[2] Russian Academy of Sciences,undefined
来源：
Neuroscience and Behavioral Physiology | 2003年 / 33卷 / 2期
关键词：
Peptide; Oxidative Stress; Protein Fragment; Stable Increase; Intracerebroventricular Administration;
D O I：
10.1023/A:1021761310435
中图分类号：
学科分类号：
摘要：
Intracerebroventricular administration of aggregated β-amyloid protein fragment (25–35) (7.5 nmol/ventricle) was followed one month later by significant changes in the dynamics of long-term potentiation in the hippocampus in vivo, expressed as powerful and stable increases in the amplitude of evoked potentials. This phenomenon may be associated with oxidative stress in the hippocampus, which has previously been demonstrated in this model, and, thus, with disturbances in ion homeostasis.
引用
收藏
页码：95 / 98
页数：3
相关论文
共 50 条
  • [1] Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in hippocampus in vivo
    Trubetskaya, VV
    Stepanichev, MY
    Onufriev, MV
    Lazareva, NA
    Markevich, VA
    Gulyaeva, NV
    ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA, 2001, 51 (06) : 690 - 693
  • [2] Conformational Features of Beta-Amyloid Peptide 25–35
    Agaeva G.A.
    Najafova G.Z.
    Biophysics, 2023, 68 (5) : 712 - 718
  • [3] Intracerebroventricular administration of beta-amyloid peptide (25-35) induces oxidative stress and neurodegeneration in rat brain
    Gulyaeva, NV
    Victorov, IV
    Stepanichev, MY
    Onufriev, MV
    Mitrokhina, OS
    Moiseeva, YV
    Lazareva, NA
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 89 - 98
  • [4] Behavioural effects of beta-amyloid peptide fragment (25-35) beta-administration in rats
    Stepanichev, MY
    Lazareva, NA
    Onufriev, MV
    Mitrokhina, OS
    Moiseeva, YV
    Gulyaeva, NV
    ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA, 1997, 47 (03) : 597 - 600
  • [5] αv intearins mediate beta-amyloid induoced inhibition of long-term potentiation
    Wang, Qinwen
    Klyubin, Igor
    Wright, Sarah
    Griswold-Prenner, Irene
    Rowan, Michael J.
    Anwyl, Roger
    NEUROBIOLOGY OF AGING, 2008, 29 (10) : 1485 - 1493
  • [6] Learning induces long-term potentiation in the hippocampus
    Whitlock, Jonathan R.
    Heynen, Arnold J.
    Shuler, Marshall G.
    Bear, Mark F.
    SCIENCE, 2006, 313 (5790) : 1093 - 1097
  • [7] Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats
    Stepanichev, MY
    Moiseeva, YV
    Lazareva, NA
    Onufriev, MV
    Gulyaeva, NV
    BRAIN RESEARCH BULLETIN, 2003, 61 (02) : 197 - 205
  • [8] Analysis of the Effect of Neuroprotectors That Reduce the Level of Degeneration of Neurons in the Rat Hippocampus Caused by Administration of Beta-Amyloid Peptide Aβ25-35
    Gordon, R. Ya
    Makarova, E. G.
    Mugantseva, E. A.
    Khutsyan, S. S.
    Kichigina, V. F.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 172 (04) : 441 - 446
  • [9] Analysis of the Effect of Neuroprotectors That Reduce the Level of Degeneration of Neurons in the Rat Hippocampus Caused by Administration of Beta-Amyloid Peptide Aβ25-35
    R. Ya. Gordon
    E. G. Makarova
    E. A. Mugantseva
    S. S. Khutsyan
    V. F. Kichigina
    Bulletin of Experimental Biology and Medicine, 2022, 172 : 441 - 446
  • [10] The neurochemical and behavioral effects of beta-amyloid peptide(25-35)
    Chen, SY
    Wright, JW
    Barnes, CD
    BRAIN RESEARCH, 1996, 720 (1-2) : 54 - 60
12345